Document is current
Any future updates will be listed below
-
Authors
Khawaja, Saud Ahmed https://orcid.org/0000-0001-5349-6087
Mohan, Poornima
Jabbour, Richard
Bampouri, Theodora
Bowsher, Gemma
Hassan, Ahmed M M https://orcid.org/0000-0003-2532-918X
Huq, Farhan
Baghdasaryan, Lilit
Wang, Brian
Sethi, Amarjit
Sen, Sayan
Petraco, Ricardo
Ruparelia, Neil
Nijjer, Sukhjinder
Malik, Iqbal
Foale, Rodney
Bellamy, Michael
Kooner, Jaspal
Rana, Bushra
Cole, Graham
Sutaria, Nilesh
Kanaganayagam, Gajen
Nihoyannopoulos, Petros
Fox, Kevin
Plymen, Carla
Pabari, Punam
Howard, Luke
Davies, Rachel
Haji, Gulammehdi
Lo Giudice, Francesco
Kanagaratnam, Prapa
Anderson, Jon
Chukwuemeka, Andrew
Khamis, Ramzi
Varnava, Amanda
Baker, Christopher S R
Francis, Darrel Parthipan
Asaria, Perviz
Al-Lamee, Rasha
Mikhail, Ghada W
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04312009 at ClinicalTrials.govDocuments that mention this clinical trial
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19
https://doi.org/10.2215/cjn.03530320
COVID-19 and its impact on the cardiovascular system
https://doi.org/10.1136/openhrt-2020-001472
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis
https://doi.org/10.1136/thoraxjnl-2020-215768
Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection
https://doi.org/10.34067/kid.0003792020
Beware of simple explanations
https://doi.org/10.1136/heartjnl-2020-317605
Manipulation of ACE2 expression in COVID-19
https://doi.org/10.1136/openhrt-2020-001424
- License Information
